1-3 of 3
Patricia Ann Boone
Close
Sort by
Journal Articles

Final Report of a Phase II Study of 5-Azacitidine and Vorinostat in Patients (pts) with Newly Diagnosed Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML) Not Eligible for Clinical Trials Because Poor Performance and Presence of Other Comorbidities

Guillermo Garcia-Manero, Elihu H Estey, MD, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Kiran Naqvi, MD, Ross L Levine, MD, Zeev Estrov, Alfonso Quintas-Cardama, MD, Marina Konopleva, M.D., Ph.D., Stefan Faderl, MD, Maria Tanaka, MD, Hui Yang, Farhad Ravandi, MD, William G. Wierda, MD, PhD, Jorge E. Cortes, Patricia Ann Boone, Hagop M. Kantarjian
Journal: Blood
Blood (2011) 118 (21): 608.
https://doi.org/10.1182/blood.V118.21.608.608
Published: 2011
Journal Articles

Phase 1/ 2 Study of Sapacitabine and Decitabine Administered Sequentially in Elderly Patients with Newly Diagnosed AML,

Farhad Ravandi, MD, Stefan Faderl, MD, Jorge E. Cortes, Guillermo Garcia-Manero, Elias Jabbour, Patricia Ann Boone, Tapan Kadia, Gautam Borthakur, William G. Wierda, MD, PhD, Meir Wetzler, MD, Parameswaran Venugopal, MD, Judy Chiao, MD, Hagop M. Kantarjian
Journal: Blood
Blood (2011) 118 (21): 3630.
https://doi.org/10.1182/blood.V118.21.3630.3630
Published: 2011
Journal Articles

Phase II Study of 5-Azacitidine and Vorinostat In Patients (pts) with Newly Diagnosed Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML) Not Eligible for Clinical Trials Because Poor Performance or Presence of Other comorbidities

Guillermo Garcia-Manero, MD, Elihu H. Estey, MD, Elias Jabbour, MD, Tapan Kadia, MD, Zeev Estrov, MD, Jorge Cortes, MD, Patricia Ann Boone, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 604.
https://doi.org/10.1182/blood.V116.21.604.604
Published: 2010